News

#BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh

#BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh
BioNTech’s stock sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below expectations, weighed down by inventory writedowns by COVID-19 vaccine collaboration partner Pfizer.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.